Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
DA5RC6
|
|||
| Drug Name |
BC-1215
|
|||
| Synonyms |
1507370-20-8; N1,N2-Bis(4-(pyridin-2-yl)benzyl)ethane-1,2-diamine; C26H26N4; N1,N2-Bis[4-(2-pyridinyl)benzyl]-1,2-ethanediamine; CHEMBL4549895; SCHEMBL16781356; AOB4428; SYN5093; EX-A4964; MFCD28118991; ZINC205895150; AS-16457; HY-117937; CS-0068629; N1,N2-Bis[[4-(2-pyridinyl)phenyl]methyl]- 1,2-ethanediamine
Click to Show/Hide
|
|||
| Drug Type |
Small molecular drug
|
|||
| Indication | Inflammation [ICD-11: 1A00-CA43.1] | Preclinical | [1] | |
| Structure |
 |
Download2D MOL |
||
| Formula |
C26H26N4
|
|||
| Canonical SMILES |
C1=CC=NC(=C1)C2=CC=C(C=C2)CNCCNCC3=CC=C(C=C3)C4=CC=CC=N4
|
|||
| InChI |
1S/C26H26N4/c1-3-15-29-25(5-1)23-11-7-21(8-12-23)19-27-17-18-28-20-22-9-13-24(14-10-22)26-6-2-4-16-30-26/h1-16,27-28H,17-20H2
|
|||
| InChIKey |
IXEPQJQQSLMESJ-UHFFFAOYSA-N
|
|||
| PubChem Compound ID | ||||
| Target and Pathway | Top | |||
|---|---|---|---|---|
| Target(s) | F-box only protein 3 (FBXO3) | Target Info | Antagonist | [1] |
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Targeting F box protein Fbxo3 to control cytokine-driven inflammation. J Immunol. 2013 Nov 15;191(10):5247-55. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.